Worthington Steel Corrects Q4 Results: Impairment Charge Rises to $112.2M, Net Loss Widens to $57.5M
WS sits 21% above its 52-week low of $27.22.
Summary
Worthington Steel corrected its Q4 fiscal 2026 results, increasing impairment charges by $17.7 million and net loss by $8.8 million due to errors in the original release.
Key Events · Earnings and Guidance · WS
-
Impairment Charge Increased
Total impairment of goodwill, long-lived, and other assets rose to $112.2 million from the originally reported $94.5 million, driven by additional long-lived asset impairments in the Electrical Steel reporting unit.
-
Net Loss Widens
Net loss attributable to controlling interest increased to $57.5 million from $48.7 million, reflecting the higher impairment and inclusion of previously omitted bridge nonrevolving loan commitment costs.
-
Internal Control Lapse
The errors were identified during year-end internal control procedures; the company states they are isolated to Q4 and do not impact prior quarters or fiscal 2027 guidance.
-
Corrected Financials Filed
A corrected earnings release and updated investor presentation were furnished as Exhibit 99.1, superseding the original June 25, 2026 filing.
Analysis · WS · Manufacturing
Worthington Steel amended its Q4 fiscal 2026 earnings, revealing additional impairment charges and costs that were missed in the original release. The total impairment charge jumped from $94.5 million to $112.2 million, and the net loss attributable to controlling interest widened from $48.7 million to $57.5 million. The corrections stem from additional long-lived asset impairments in the Electrical Steel unit and previously excluded bridge loan commitment costs. While the company states these adjustments do not impact fiscal 2027 guidance, the magnitude of the restatement—an 18% increase in impairment and a 18% wider net loss—raises concerns about internal controls during a period of high acquisition-related complexity.
At the time of this filing, WS was trading at $33.05 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $27.22 to $49.17. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.